Ledger.Open graph →
SEC Form D · filed February 12, 2025

Sensorium Therapeutics, Inc

Offering
$38.5M
Sold
$14.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

David Southwell · Boston, MADirectorRichard Simon · New York, NYDirectorJerrold Rosenbaum · Waltham, MADirectorBalkrishan Gill · Wayne, PADirectorAlexandra Glucksmann · Cambridge, MAExec · DirectorRyan Katz · Atlanta, GADirectorKevin Lalande · Austin, TXDirectorDavid Southwell · Waltham, MADirectorRichard Simon · Waltham, MADirectorJerrold Rosenbaum · Waltham, MADirectorBalkrishan Gill · Philadelphia, PADirectorAlexandra Glucksmann · Cambridge, MAExec · DirectorRyan Katz · Rockville, MDDirectorKevin Lalande · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗